Menometrorrhagia  ||| S:0 E:17 ||| NNP
during  ||| S:17 E:24 ||| IN
the  ||| S:24 E:28 ||| DT
premenopause ||| S:28 E:40 ||| NN
:  ||| S:40 E:42 ||| :
an  ||| S:42 E:45 ||| DT
overview  ||| S:45 E:54 ||| JJ
Menometrorrhagia ||| S:54 E:70 ||| NNP
,  ||| S:70 E:72 ||| ,
defined  ||| S:72 E:80 ||| VBN
as  ||| S:80 E:83 ||| IN
excessive  ||| S:83 E:93 ||| JJ
and  ||| S:93 E:97 ||| CC
prolonged  ||| S:97 E:107 ||| JJ
uterine  ||| S:107 E:115 ||| NNS
bleeding  ||| S:115 E:124 ||| VBP
occurring  ||| S:124 E:134 ||| VBG
at  ||| S:134 E:137 ||| IN
irregular  ||| S:137 E:147 ||| NN
and ||| S:147 E:150 ||| CC
/ ||| S:150 E:151 ||| NNP
or  ||| S:151 E:154 ||| CC
frequent  ||| S:154 E:163 ||| JJ
intervals ||| S:163 E:172 ||| NNS
,  ||| S:172 E:174 ||| ,
occurs  ||| S:174 E:181 ||| VBZ
in  ||| S:181 E:184 ||| IN
up  ||| S:184 E:187 ||| RB
to  ||| S:187 E:190 ||| TO
24 ||| S:190 E:192 ||| CD
%  ||| S:192 E:194 ||| NN
of  ||| S:194 E:197 ||| IN
women  ||| S:197 E:203 ||| NNS
aged  ||| S:203 E:208 ||| VBN
40-50  ||| S:208 E:214 ||| CD
years ||| S:214 E:219 ||| NNS
.  ||| S:219 E:221 ||| .
There  ||| S:221 E:227 ||| EX
are  ||| S:227 E:231 ||| VBP
a  ||| S:231 E:233 ||| DT
wide  ||| S:233 E:238 ||| JJ
range  ||| S:238 E:244 ||| NN
of  ||| S:244 E:247 ||| IN
causes  ||| S:247 E:254 ||| NNS
of  ||| S:254 E:257 ||| IN
menometrorrhagia ||| S:257 E:273 ||| NN
,  ||| S:273 E:275 ||| ,
although  ||| S:275 E:284 ||| IN
histological  ||| S:284 E:297 ||| JJ
differences  ||| S:297 E:309 ||| NNS
in  ||| S:309 E:312 ||| IN
endometrium  ||| S:312 E:324 ||| NN
between  ||| S:324 E:332 ||| IN
women  ||| S:332 E:338 ||| NNS
aged  ||| S:338 E:343 ||| VBN
< ||| S:343 E:344 ||| SYM
45  ||| S:344 E:347 ||| CD
years  ||| S:347 E:353 ||| NNS
compared  ||| S:353 E:362 ||| VBN
with  ||| S:362 E:367 ||| IN
those  ||| S:367 E:373 ||| DT
aged  ||| S:373 E:378 ||| VBN
48-50  ||| S:378 E:384 ||| CD
years  ||| S:384 E:390 ||| NNS
indicate  ||| S:390 E:399 ||| VBP
a  ||| S:399 E:401 ||| DT
much  ||| S:401 E:406 ||| RB
higher  ||| S:406 E:413 ||| JJR
prevalence  ||| S:413 E:424 ||| NN
of  ||| S:424 E:427 ||| IN
myomas ||| S:427 E:433 ||| NN
,  ||| S:433 E:435 ||| ,
adenomyosis ||| S:435 E:446 ||| NN
,  ||| S:446 E:448 ||| ,
and  ||| S:448 E:452 ||| CC
dysfunctional  ||| S:452 E:466 ||| JJ
endometrium  ||| S:466 E:478 ||| NNS
( ||| S:478 E:479 ||| -LRB-
dysfunctional  ||| S:479 E:493 ||| FW
uterine  ||| S:493 E:501 ||| FW
bleeding ||| S:501 E:509 ||| FW
,  ||| S:509 E:511 ||| ,
hyperplasia ||| S:511 E:522 ||| NN
,  ||| S:522 E:524 ||| ,
neoplasia ||| S:524 E:533 ||| CD
)  ||| S:533 E:535 ||| -RRB-
around  ||| S:535 E:542 ||| IN
the  ||| S:542 E:546 ||| DT
time  ||| S:546 E:551 ||| NN
of  ||| S:551 E:554 ||| IN
the  ||| S:554 E:558 ||| DT
premenopause ||| S:558 E:570 ||| NN
,  ||| S:570 E:572 ||| ,
emphasizing  ||| S:572 E:584 ||| VBG
the  ||| S:584 E:588 ||| DT
importance  ||| S:588 E:599 ||| NN
of  ||| S:599 E:602 ||| IN
accurate  ||| S:602 E:611 ||| JJ
diagnosis  ||| S:611 E:621 ||| NN
and  ||| S:621 E:625 ||| CC
appropriate  ||| S:625 E:637 ||| JJ
management  ||| S:637 E:648 ||| NN
in  ||| S:648 E:651 ||| IN
women  ||| S:651 E:657 ||| NNS
of  ||| S:657 E:660 ||| IN
this  ||| S:660 E:665 ||| DT
age  ||| S:665 E:669 ||| NN
group ||| S:669 E:674 ||| NN
.  ||| S:674 E:676 ||| .
In  ||| S:676 E:679 ||| IN
women  ||| S:679 E:685 ||| NNS
presenting  ||| S:685 E:696 ||| VBG
with  ||| S:696 E:701 ||| IN
menometrorrhagia ||| S:701 E:717 ||| NN
,  ||| S:717 E:719 ||| ,
it  ||| S:719 E:722 ||| PRP
is  ||| S:722 E:725 ||| VBZ
imperative  ||| S:725 E:736 ||| VBN
to  ||| S:736 E:739 ||| TO
recognize  ||| S:739 E:749 ||| VB
that  ||| S:749 E:754 ||| DT
underlying  ||| S:754 E:765 ||| JJ
lesions  ||| S:765 E:773 ||| NNS
and  ||| S:773 E:777 ||| CC
diagnosis  ||| S:777 E:787 ||| NNS
are  ||| S:787 E:791 ||| VBP
frequently  ||| S:791 E:802 ||| RB
missed  ||| S:802 E:809 ||| VBN
due  ||| S:809 E:813 ||| JJ
to  ||| S:813 E:816 ||| TO
multiple  ||| S:816 E:825 ||| JJ
causes ||| S:825 E:831 ||| NNS
.  ||| S:831 E:833 ||| .
Primary  ||| S:833 E:841 ||| JJ
diagnosis  ||| S:841 E:851 ||| NN
needs  ||| S:851 E:857 ||| VBZ
to  ||| S:857 E:860 ||| TO
exclude  ||| S:860 E:868 ||| VB
pregnancy  ||| S:868 E:878 ||| NN
and  ||| S:878 E:882 ||| CC
cancer ||| S:882 E:888 ||| NN
,  ||| S:888 E:890 ||| ,
whereas  ||| S:890 E:898 ||| IN
secondary  ||| S:898 E:908 ||| JJ
investigations  ||| S:908 E:923 ||| NNS
( ||| S:923 E:924 ||| -LRB-
including  ||| S:924 E:934 ||| VBG
ultrasound  ||| S:934 E:945 ||| NN
with  ||| S:945 E:950 ||| IN
instillation  ||| S:950 E:963 ||| NN
of  ||| S:963 E:966 ||| IN
saline  ||| S:966 E:973 ||| JJ
solution ||| S:973 E:981 ||| NN
,  ||| S:981 E:983 ||| ,
hysteroscopy  ||| S:983 E:996 ||| NN
and  ||| S:996 E:1000 ||| CC
biopsy ||| S:1000 E:1006 ||| NN
,  ||| S:1006 E:1008 ||| ,
and  ||| S:1008 E:1012 ||| CC
magnetic  ||| S:1012 E:1021 ||| JJ
resonance  ||| S:1021 E:1031 ||| NN
imaging ||| S:1031 E:1038 ||| NN
)  ||| S:1038 E:1040 ||| -RRB-
can  ||| S:1040 E:1044 ||| MD
assist  ||| S:1044 E:1051 ||| VB
in  ||| S:1051 E:1054 ||| IN
accurately  ||| S:1054 E:1065 ||| RB
diagnosing  ||| S:1065 E:1076 ||| VBG
the  ||| S:1076 E:1080 ||| DT
underlying  ||| S:1080 E:1091 ||| JJ
cause  ||| S:1091 E:1097 ||| NN
of  ||| S:1097 E:1100 ||| IN
menometrorrhagia ||| S:1100 E:1116 ||| NN
.  ||| S:1116 E:1118 ||| .
